Debevoise & Plimpton LLP has advised Advantage Partners in the final close of Advantage Partners Asia Fund II (the “Fund”), which closed with $424 million in total commitments.

The Fund continues Advantage Partners’ Asia strategy of investing in control buyouts of mid-cap companies in Asia ex-Japan, drawing on the firm’s operational and strategic capabilities developed in Japan and its Japan-linked value creation approach.

The Fund was raised from a globally diversified investor base, including returning and new limited partners across Japan, Asia, Europe and North America, despite a challenging global fundraising environment.

Advantage Partners Asia Fund II has completed its first investment in ITS Science & Medical in Singapore and has an active pipeline across Asia.

For full details, see the official release here.

The Debevoise team advising Advantage Partners was led by partners Gavin Anderson and Shawn Yang, and included associates Cecilia Chung, Erica Chen, Yueting Chen and David Gao. Tax advice was provided by partner Mai Shapiro, and associate Sophia Huang.